VCEL
Vericel Corporation
NASDAQ · Healthcare · Biotechnology · US
$40.19
−0.69%Aug 15, 2026, 07:33 UTC
Bank of America Corp DE increased its stake in Vericel Corporation by 19.7% during the quarter, acquiring an additional 180,761 shares, according to its SEC disclosure.
Source:Jul 30, 2026, 11:55 UTC
Vericel Corporation's Board of Directors authorized a $200 million share repurchase program.
Jul 30, 2026, 11:55 UTC
Vericel Corporation reported financial results for the second quarter ended June 30, 2026, with total net revenue of $77.5 million, net income of $2.2 million, and free cash flow of $14.3 million.